LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,689 | -52.4% | 42,834 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $98,090 | -5.8% | 42,834 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $104,087 | +149.6% | 42,834 | +96.2% | 0.00% | – |
| Q4 2022 | $41,705 | -56.6% | 21,835 | -45.5% | 0.00% | -100.0% |
| Q3 2022 | $96,134 | -4.7% | 40,056 | +56.4% | 0.00% | 0.0% |
| Q4 2021 | $100,880 | -18.1% | 25,604 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $123,155 | -17.9% | 25,604 | +7.4% | 0.00% | -50.0% |
| Q2 2019 | $149,972 | +13.1% | 23,843 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $132,567 | -16.3% | 23,843 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $158,318 | -37.8% | 23,843 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $254,405 | -11.0% | 23,843 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $286,000 | +40.2% | 23,843 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $204,000 | -13.6% | 23,843 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $236,000 | – | 23,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |